Skip to main content
Vineet Laboratories Limited logo

Vineet Laboratories Limited — Investor Relations & Filings

Ticker · VINEETLAB ISIN · INE505Y01010 LEI · 98450053FEE2D64C6147 BSE.NS Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2023-08-14 Legal Proceedings Report
Country IN India
Listing BSE.NS VINEETLAB

About Vineet Laboratories Limited

http://vineetlabs.co.in/

Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Legal Proceedings Report Classification · 95% confidence The document contains a possession notice issued by an authorized officer of HDB Financial Services Ltd. under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest Act, 2002. This notice informs about the taking possession of immovable property due to non-repayment of a loan. The document also includes an extract of unaudited standalone financial results for Suryaamba Spinning Mills Ltd. for the quarter ended June 30, 2023, with details on income, profit, and other financial metrics, along with notes about the audit committee and limited review report. However, the primary and most prominent content is the possession notice related to enforcement of security interest, which is a legal enforcement action rather than a financial report or earnings release. The possession notice is a formal announcement of taking possession of secured assets under a legal framework, which aligns with a legal proceedings or enforcement action. Given the nature of the possession notice and the legal context, the document is best classified as a Legal Proceedings Report (LTR). The financial results extract is secondary and does not dominate the document's purpose. Therefore, the classification is LTR with high confidence.
2023-08-14 English
Financial Result Updates
Regulatory Filings
2023-08-12 English
Board Meeting — VINEET LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company f…
Regulatory Filings
2023-08-04 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the scheduling of a Board Meeting. It specifically mentions the agenda to consider and approve unaudited financial results for the first quarter ended June 30, 2023. The document also references regulatory compliance under SEBI regulations and insider trading rules. The content is an announcement of an upcoming board meeting and not the financial results or report itself. The document length is short (1682 characters) and serves as an intimation rather than containing substantive financial data or analysis. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements related to board meetings and management activities.
2023-08-04 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the closure of the trading window in compliance with SEBI regulations. It specifically mentions the trading window closure period related to the upcoming declaration of unaudited financial results for the first quarter ended June 30, 2023. There is no actual financial data, report, or detailed financial analysis included. The document is an announcement related to regulatory compliance and insider trading restrictions rather than a financial report or earnings release. Given the short length (1485 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2023-06-29 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.